Placental Mesenchymal Stem Cells ( DrugBank: Placental Mesenchymal Stem Cells )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 118 | 脊髄髄膜瘤 | 1 |
118. 脊髄髄膜瘤
臨床試験数 : 5 / 薬物数 : 7 - (DrugBank : 4) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 10
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04652908 (ClinicalTrials.gov) | June 21, 2021 | 25/11/2020 | Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial | Phase 1/2a Trial of Placental Mesenchymal Stem Cells for Repair of Fetal Myelomeningocele | Myelomeningocele | Biological: Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix;Other: Untreated contemporaneous cohort | Diana Lee Farmer | California Institute for Regenerative Medicine (CIRM) | Recruiting | 19 Weeks | 25 Weeks | All | 55 | Phase 1/Phase 2 | United States |